Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II interventional trial for the assessment of histological responses in all resected colorectal cancer liver metastases after preoperative cetuximab-based chemotherapy. [Ensayo clinico fase II para la evaluacion de las respuestas histologicas de todas las metastasis hepaticas resecadas en pacientes con Cancer colorectal metastasico tras quimioterapia preoperatoria basada en Cetuximab]

Next Previous
X
Search
Trial Profile

Phase II interventional trial for the assessment of histological responses in all resected colorectal cancer liver metastases after preoperative cetuximab-based chemotherapy. [Ensayo clinico fase II para la evaluacion de las respuestas histologicas de todas las metastasis hepaticas resecadas en pacientes con Cancer colorectal metastasico tras quimioterapia preoperatoria basada en Cetuximab]

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
  • Indications Liver metastases
  • Focus Therapeutic Use
  • Acronyms ERBIMET

    • Most Recent Events

    • 07 Dec 2015 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 10 Sep 2013 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top